| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31aeb7ff63fed1cd36b3ed8ec8bc669e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf6edae5250129896be5ca2e33a61ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5d546aa6cbfb52c137af7cafc36bf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e528fc8ac6cfe100f8f8a5ba030951a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bed555f1441f207e1eadd891dc260c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19140c2ad52f0959f26c0256b84f6b57 |
| publicationDate |
2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012046745-A1 |
| titleOfInvention |
Therapeutic agent for malignant tumors expressing mhc class ii |
| abstract |
Provided is a new specific therapeutic agent for malignant tumors expressing MHC class II. Provided is an antigen which recognizes proteins that constitute MHC class II expressed on malignant tumors, and which contains at least one among a heavy chain CDR1 (amino acid sequence represented by positions 49-54 of Sequence ID 54), a heavy chain CDR2 (amino acid sequence represented by positions 69-84 of Sequence ID 54), a heavy chain CDR3 (amino acid sequence represented by positions 117-128 of Sequence ID 54), a light chain CDR1 (amino acid sequence represented by positions 46-55 of Sequence ID 56), a light chain CDR2 (amino acid sequence represented by positions 71-77 of Sequence ID 56), and a light chain CDR3 (amino acid sequence represented by positions 100-108 of Sequence ID 56). |
| priorityDate |
2010-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |